Publications by authors named "Noam Epstein"

Claim this Profile
U
Using the ALSFRS-R in multicentre clinical trials for amyotrophic lateral sclerosis: potential limitations in current standard operating procedures.
Jaap N E Bakers, Adriaan D de Jongh, Tommy M Bunte, Lindsay Kendall, Steve S Han, Noam Epstein

Amyotroph Lateral Scler Frontotemporal Degener· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the pharmacokinetics of pemigatinib in patients with impaired hepatic or renal function.
Tao Ji, Kevin Rockich, Noam Epstein, Heather Overholt, Phillip Wang

Br J Clin Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of drug-drug interactions of pemigatinib in healthy participants.
Tao Ji, Kevin Rockich, Noam Epstein, Heather Overholt, Phillip Wang

Eur J Clin Pharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Evaluation of drug‑drug interactions of pemigatinib in healthy participants.
Tao Ji, Kevin Rockich, Noam Epstein, Heather Overholt, Phillip Wang

Eur J Clin Pharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established Order.
Ruben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, Lindsay Kendall, Steve S Han, Noam Epstein

Neurology· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Hepatic Impairment on the Pharmacokinetics of Itacitinib.
April M Barbour, Kevin Rockich, Evan Cimino, Gongfu Zhou, Caterina Leonetti-Whalen, Noam Epstein

J Clin Pharmacol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Label Study to Assess the Effect of Itraconazole and Rifampin on Parsaclisib Pharmacokinetics When Administered Orally in Healthy Participants.
Jia Li, Kevin Rockich, Brad Yuska, Gongfu Zhou, Noam Epstein

J Clin Pharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Clinical Cardiac Safety of Itacitinib, a JAK1 Inhibitor, in Healthy Participants.
Xiaohua Gong, Borje Darpo, Hongqi Xue, Naresh Punwani, Kevin He, Noam Epstein

Clin Pharmacol Drug Dev· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Renal Impairment on the Pharmacokinetics and Safety of Itacitinib.
Nithya Srinivas, April M Barbour, Noam Epstein, Gongfu Zhou, Susan Petusky

J Clin Pharmacol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Itraconazole or Rifampin on Itacitinib Pharmacokinetics When Administered Orally in Healthy Subjects.
April M Barbour, Naresh Punwani, Noam Epstein, Robert Landman, Evan Cimino

J Clin Pharmacol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visit-to-visit systolic blood pressure variability and microvascular complications among patients with diabetes.
Min-Woong Sohn, Noam Epstein, Elbert S Huang, Zhiping Huo, Nicholas Emanuele

J Diabetes Complications· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systolic blood pressure variability and lower extremity amputation in a non-elderly population with diabetes.
Elly Budiman-Mak, Noam Epstein, Meghan Brennan, Rodney Stuck, Marylou Guihan

Diabetes Res Clin Pract· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substantial effect of efavirenz monotherapy on bilirubin levels in healthy volunteers.
Ingrid F Metzger, Troy C Quigg, Noam Epstein, Abdulateef O Aregbe, Nancy Thong

Curr Ther Res Clin Exp· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication for Alzheimer's disease and associated fall hazard: a retrospective cohort study from the Alzheimer's Disease Neuroimaging Initiative.
Noam U Epstein, Rong Guo, Martin R Farlow, Jaswinder P Singh, Morris Fisher

Drugs Aging· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive dysfunction and greater visit-to-visit systolic blood pressure variability.
Noam U Epstein, Kathleen A Lane, Martin R Farlow, Shannon L Risacher, Andrew J Saykin

J Am Geriatr Soc· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular risk factors and cardiovascular outcomes in the Alzheimer's disease neuroimaging initiative.
Noam U Epstein, Hui Xie, Sean D Ruland, Dilip K Pandey,

Am J Alzheimers Dis Other Demen· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics.
Noam U Epstein, Andrew J Saykin, Shannon L Risacher, Sujuan Gao, Martin R Farlow

Drugs Aging· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis